The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Funicular Funds and Cable Car Capital have reported a combined 5.2% beneficial ownership stake in Nasus Pharma Ltd (NSRX). The ownership was disclosed through an SEC Schedule 13G filing, characterizing the position as a passive investment. According to the filing, the investment groups collectively hold 612,913 ordinary shares based on the company's total shares outstanding. This disclosure was triggered by the entities crossing the regulatory 5% ownership threshold, requiring formal reporting to the SEC. While the investment is designated as passive, the accumulation of shares by institutional players is often viewed as a vote of confidence in the firm's valuation. Nasus Pharma now sees increased institutional backing following this strategic position by Jacob Ma-Weaver and his associated funds.
Sign up free to access this content
Create Free Account